Collective Family Office’s Pfizer PFE Stock Holding History

Collective Family Office’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,371	Closed	-$311K	–	181
2023 Q3	$311K	Sell	9,371 -2,909	-24%	-$103K	0.12%	127
2023 Q2	$450K	Sell	12,280 -3,705	-23%	-$144K	0.18%	112
2023 Q1	$652K	Buy	15,985 +2,301	+17%	+$99.4K	0.27%	83
2022 Q4	$701K	Sell	13,684 -1,519	-10%	-$72.8K	0.32%	74
2022 Q3	$665K	Sell	15,203 -4,570	-23%	-$222K	0.33%	79
2022 Q2	$1.04M	Buy	19,773 +274	+1%	+$14K	0.45%	65
2022 Q1	$1.01M	Buy	19,499 +1,976	+11%	+$103K	0.39%	71
2021 Q4	$1.03M	Buy	17,523 +579	+3%	+$28.7K	0.41%	66
2021 Q3	$729K	Sell	16,944 -1,484	-8%	-$65.7K	0.31%	77
2021 Q2	$722K	Buy	18,428 +3	+0%	+$117	0.31%	82
2021 Q1	$668K	Buy	18,425 +3,207	+21%	+$114K	0.33%	80
2020 Q4	$560K	Buy	+15,218	New	+$558K	0.31%	80

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Collective Family Office's PFE Position: Q4 2023 in Review

Collective Family Office sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,371 shares — an estimated $311K sold.

Collective Family Office first reported a position in PFE in Q4 2020 and held it in 12 quarters. The position peaked at $1.04M in Q2 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Collective Family Office reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Collective Family Office sold 9,371 Pfizer shares in Q4 2023, an estimated $311K.
Collective Family Office first reported a position in Pfizer in Q4 2020 and held it in 12 quarters.
Collective Family Office's Pfizer position peaked at $1.04M in Q2 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Collective Family Office's 13F filing for Q4 2023, filed 9 Jan 2024.